Pages that link to "Q37298457"
Jump to navigation
Jump to search
The following pages link to Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology (Q37298457):
Displaying 40 items.
- Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing (Q33804206) (← links)
- Commensal bacteria make GPCR ligands that mimic human signalling molecules (Q38635610) (← links)
- The gut microbiome and liver cancer: mechanisms and clinical translation. (Q39414187) (← links)
- Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury (Q40229016) (← links)
- Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step (Q41706834) (← links)
- The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma (Q44987249) (← links)
- Microbiota, cirrhosis, and the emerging oral-gut-liver axis (Q45069266) (← links)
- Disturbance in Plasma Metabolic Profile in Different Types of Human Cytomegalovirus-Induced Liver Injury in Infants (Q45867066) (← links)
- Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis (Q46263809) (← links)
- Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation (Q47428111) (← links)
- The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease (Q50052495) (← links)
- Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study (Q57117007) (← links)
- On Controls in Ancient Microbiome Studies, and Microbial Resilience in Ancient Samples (Q57213207) (← links)
- Influence of cigarette smoking on the human duodenal mucosa-associated microbiota (Q58694782) (← links)
- Mucosal microbiota of intestinal polyps reveals putative biomarkers of colorectal cancer (Q58726363) (← links)
- Clinical impact of microbiome in patients with decompensated cirrhosis (Q58740370) (← links)
- Stunted childhood growth is associated with decompartmentalization of the gastrointestinal tract and overgrowth of oropharyngeal taxa (Q62489043) (← links)
- Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence (Q64232221) (← links)
- The gut-liver axis and the intersection with the microbiome (Q88634168) (← links)
- Publisher Correction: The gut-liver axis and the intersection with the microbiome (Q88764776) (← links)
- Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis (Q89184123) (← links)
- The role of the gut microbiome in chronic liver disease: the clinical evidence revised (Q89624002) (← links)
- Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice (Q95003661) (← links)
- Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome (Q90031017) (← links)
- ADAM17-Mediated Reduction in CD14 CD16 Monocytes ex vivo and Reduction in Intermediate Monocytes With Immune Paresis in Acute Pancreatitis and Acute Alcoholic Hepatitis (Q90050597) (← links)
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders (Q90171305) (← links)
- Akkermansia muciniphila in the Human Gastrointestinal Tract: When, Where, and How? (Q90446843) (← links)
- Gut microbiota perturbation is associated with acute sleep disturbance among rectal cancer patients (Q90625311) (← links)
- Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial (Q91639788) (← links)
- Change of the duodenal mucosa-associated microbiota is related to intestinal metaplasia (Q91797694) (← links)
- Fecal Microbiome Data Distinguish Liver Recipients With Normal and Abnormal Liver Function From Healthy Controls (Q92106575) (← links)
- Advances in Gut Microbiota of Viral Hepatitis Cirrhosis (Q92313773) (← links)
- Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease (Q92367156) (← links)
- MicroPro: using metagenomic unmapped reads to provide insights into human microbiota and disease associations (Q92458051) (← links)
- Targeting Microbiota: What Do We Know about It at Present? (Q92570756) (← links)
- Current Knowledge about the Effect of Nutritional Status, Supplemented Nutrition Diet, and Gut Microbiota on Hepatic Ischemia-Reperfusion and Regeneration in Liver Surgery (Q92882471) (← links)
- Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? (Q92999660) (← links)
- The microbial abundance dynamics of the paediatric oral cavity before and after sleep (Q93271752) (← links)
- The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in Nonalcoholic Steatohepatitis (Q98467815) (← links)
- Role of Microbiota in Pathogenesis and Management of Viral Hepatitis (Q98771307) (← links)